FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 360 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 360 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 360 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 360 | +29.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 279 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -15.8% | 279 | -14.4% | 0.00% | – |
| Q3 2021 | $19,000 | +18.8% | 326 | +75.3% | 0.00% | – |
| Q2 2021 | $16,000 | +6.7% | 186 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | 0.0% | 186 | +13.4% | 0.00% | – |
| Q4 2020 | $15,000 | -25.0% | 164 | -66.5% | 0.00% | – |
| Q3 2020 | $20,000 | +122.2% | 490 | +19.5% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 410 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | +12.5% | 410 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +33.3% | 410 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 410 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | +14.3% | 410 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | 0.0% | 410 | -25.5% | 0.00% | – |
| Q4 2018 | $7,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |